The minimum inhibitory concentrations of penicillin and cephalothin necessary to inhibit growth of most anaerobic bacteria were reduced to a susceptible level by 1 to 5 gg of clavulanic acid per ml. In most cases, minimum inhibitory concentrations of cefoxitin were not affected.
Clavulanic acid is a new beta-lactamase inhibitor produced by Streptomyces clavuligerus ATCC 27064. It resembles the nucleus of penicillin but differs in several ways. It has no acylamino side chain, sulfur is replaced by oxygen, and it contains a beta-hydroxyethylidine substituent in the oxazolidine ring. Clavulanic acid irreversibly inhibits beta-lactamase enzymes produced by some Enterobacteriaceae (mainly R factor-mediated beta-lactamases) and staphylococci (11) . Used in conjunction with a beta-lactam antibiotic, it may prove to be effective in treating infections caused by beta-lactamase-producing bacteria. Its usefulness in the chemotherapy of human infections is currently being evaluated.
Although there have been several reports that resistance of anaerobic bacteria to betalactam antibiotics is at least partially caused by beta-lactamase (1, 4, 9, 10, 13, 14) , little is known about the effect of clavulanic acid on the susceptibility of these bacteria ( 20 ,ug of clavulanic acid per ml, although these strains are known to produce beta-lactamase (14) . Possibly the clostridial beta-lactamases are not susceptible to clavulanic acid in the concentrations tested.
With amoxycillin, similar results to the ones obtained with penicillin were found.
Since the bacteria (with the exception of the relatively rare B. fragilis homology group II and two clostridia) became essentially susceptible to the beta-lactam antibiotics tested in the presence of clavulanic acid, the main mechanism of resistance in these strains seems to TABLZ be formation of beta-lactamase. However, it is sometimes difficult to demonstrate beta-lactamase production in anaerobic bacteria, especially in the B. fragilis group, and amounts of enzyme found are low (1, 4, 9, 10, 13, 14) . The difficulties encountered in assaying beta-lactamases may be caused by technical problems such as inhibited release of the enzyme from the cell or instability of the enzyme.
